PERCUTANEOUSLY IMPLANTABLE MEDICAL DEVICE CONFIGURED TO PROMOTE TISSUE INGROWTH
    2.
    发明公开
    PERCUTANEOUSLY IMPLANTABLE MEDICAL DEVICE CONFIGURED TO PROMOTE TISSUE INGROWTH 有权
    经皮植入医疗促进组织生长

    公开(公告)号:EP1613252A2

    公开(公告)日:2006-01-11

    申请号:EP04759389.2

    申请日:2004-04-09

    IPC分类号: A61F6/00

    摘要: An implantable device (42) including a housing having a stud (62) projecting percutaneously through an incision in the patient's skin. The stud (62) defines a peripheral surface (66) extending longitudinally inwardly from the stud (62) outer end. The longitudinal peripheral surface (66) is used as a substrate to carry a peripheral fibrous layer (70) which extends longitudinally along the stud (62)from its outer end adjacent to the skin incision to below the patient's epidermal and dermal skin layers for promoting laterally directed soft tissue in growth. The housing (42) also defines a lateral shoulder surface (60) oriented substantially perpendicular to the longitudinal peripheral surface (66). The shoulder surface (60), when implanted, is located just inwardly from the patient's outer skin surface. The shoulder surface (60) also carries a porous layer conducive to promoting tissue in growth (72). The provision of both lateral and longitudinal porous layers on the device allows tissue in growth, i.e., tissue growth into the interstices of both porous layers to form an enhanced infection resistant barrier while also providing improved device anchoring.

    MEDICAL APPARATUS AND METHOD FOR FACILITATING THE MANAGEMENT OF LONG TERM TUNNELED CONDUITS
    3.
    发明公开
    MEDICAL APPARATUS AND METHOD FOR FACILITATING THE MANAGEMENT OF LONG TERM TUNNELED CONDUITS 审中-公开
    医疗器械和方法,便于长期隧道线路的控制

    公开(公告)号:EP2203139A1

    公开(公告)日:2010-07-07

    申请号:EP08838073.8

    申请日:2008-10-01

    IPC分类号: A61F13/02

    摘要: A method and apparatus for facilitating the management of indwelling conduits to avoid and/or treat infections associated with long term implantation. A sleeve carrying a layer of porous material on its outer surface is percutaneous implanted to place the layer of porous material just under the patient's outer skin in contact with the patient's dermis where it functions to promote soft tissue ingrowth. A catheter passes through the sleeve passageway and along an interior body path to an interior destination site, e.g., an opening into a vein, i.e., venotomy site. Within about 3-6 weeks after implantation, the patient's dermal tissue integrates sufficiently with the sleeve porous material to physically anchor the sleeve and create an infection resistant barrier. Further, a tunnel, characterized by an epithelialized capsule, typically forms around the catheter along the interior body path extending to the interior destination site. After sufficient integration of the patient's soft tissue into the porous layer, the sleeve passageway can be used to pass various procedural tools to the tunnel and interior destination site without disturbing the tissue integrating barrier.